CRISPR-Based RNA Silencing Proposed for Enhancing Donor Organ Quality

A recent article suggests integrating CRISPR-based RNA silencing into the ex vivo machine perfusion process for donor organs. This innovative approach aims to improve the quality of organs and reduce pathogen presence before transplantation. The method offers a significant scientific application of CRISPR technology without directly altering patient genomes.